|
Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Tuberculosis
|
NIAID
|
5R01AI036973-14
|
|
Gene Regulation and Virulence in TB and MAC
|
BISHAI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$381,367
|
Tuberculosis
|
NIAID
|
5R01AI067731-03
|
|
Antigen-specific CD8+ T cells and protective immunity to tuberculosis
|
BEHAR, SAMUEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$393,521
|
Tuberculosis
|
NIAID
|
5R01AI046428-09
|
|
Gene Expression in Mycobacterium Tuberculosis
|
CLARK-CURTISS, JOSEPHINE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$312,886
|
Tuberculosis
|
NIAID
|
5R01AI035726-13
|
|
Class II MHC Transport and Function
|
HARDING, CLIFFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$367,923
|
Tuberculosis
|
NIGMS
|
5R01GM038130-15
|
|
Investigations of the Bioinorganic Chemistry of Iron: New Siderophores
|
BUTLER, ALISON
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$247,651
|
Tuberculosis
|
NIAID
|
5R01AI055352-05
|
|
Novel Antimicrobial Agents Against M. tuberculosis
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$454,104
|
Tuberculosis
|
NIAID
|
5R01AI069085-02
|
|
M. tuberculosis lipoprotein-TLR2 interactions
|
HARDING, CLIFFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$378,911
|
Tuberculosis
|
NIAID
|
5R01AI069345-02
|
|
Autophagy in Tuberculosis
|
DERETIC, VOJO
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$365,423
|
Tuberculosis
|
NIAID
|
5R01AI037901-11
|
|
Characterization of Mycobacterial Sigma Factors
|
HUSSON, ROBERT
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$416,676
|
Tuberculosis
|
NIAID
|
5R01AI035237-13
|
|
Nramp1 in macrophage defences against infections
|
GROS, PHILIPPE
|
MCGILL UNIVERSITY
|
CANADA
|
$175,801
|
Tuberculosis
|
NIAID
|
5R01AI059639-04
|
|
TB and Innate Immune Regulation of Lung Macrophages
|
SCHLESINGER, LARRY
|
OHIO STATE UNIVERSITY
|
OH
|
$278,119
|
Tuberculosis
|
NIAID
|
5K08AI063101-04
|
|
TNF and Granuloma Formation in Tuberculosis
|
LIN, PHILANA
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$120,148
|
Tuberculosis
|
NIAID
|
5R01AI052458-03
|
|
Altered M. tuberculosis Mannosylation and the Macrophage
|
SCHLESINGER, LARRY
|
OHIO STATE UNIVERSITY
|
OH
|
$355,426
|
Tuberculosis
|
NIAID
|
5R01AI048090-07
|
|
Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
|
LEWINSOHN, DAVID
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$315,746
|
Tuberculosis
|
NIAID
|
5R01AI044639-08
|
|
Targetting InhA For Anti-TB Drug Discovery
|
TONGE, PETER
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$205,756
|
Tuberculosis
|
NIAID
|
5R01AI067027-03
|
|
Enviromental cues and responses in tuberculosis
|
RUSSELL, DAVID
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$366,137
|
Tuberculosis
|
NIAID
|
5R01AI054629-04
|
|
The role of NK cells in human M. Tuberculosis infection
|
VANKAYALAPATI, RAMAKRISHNA
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$255,795
|
Tuberculosis
|
NIAAA
|
5R01AA011760-10
|
|
Alcohol and Reactivation TB
|
MASON, CAROL
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$302,944
|
Tuberculosis
|
NHLBI
|
5R01HL053306-13
|
|
Cholesterol Oxidase Loop Residues and Catalysis
|
SAMPSON, NICOLE
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$353,643
|
Tuberculosis
|
NIAID
|
5R01AI037856-10
|
|
Mycobacterium tuberculosis Survival Regulatory Genes
|
BISHAI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$380,205
|
Tuberculosis
|
NIAID
|
5R01AI046582-09
|
|
Search for novel TB Drug Targets in Lipid Metabolism
|
KOLATTUKUDY, PAPPACHAN
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$332,534
|
Tuberculosis
|
NIDA
|
5F30DA019363-04
|
|
Treatment and Control of Mycobacterial Infections
|
YU, JOHN-PAUL
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$23,522
|
Tuberculosis
|
NIAID
|
5R03AI063576-02
|
|
Comparative Genomics and Pathogenesis of Tuberculosis
|
HOLMES, SUSAN
|
STANFORD UNIVERSITY
|
CA
|
$66,798
|
Tuberculosis
|
NIAID
|
5U01AI069474-02
|
|
The Ohio State University AIDS Clinical Trials Unit
|
KOLETAR, SUSAN
|
OHIO STATE UNIVERSITY
|
OH
|
$2,542,078
|
Tuberculosis
|
NIAID
|
5R01AI068413-03
|
|
A TB Vaccine for AIDS Patients
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$655,618
|
Tuberculosis
|
NIAID
|
5R21AI066235-02
|
|
In vivo Transcriptional Analysis of Latent Tuberculosis
|
TALAAT, ADEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$144,207
|
Tuberculosis
|
NIAID
|
5R01AI069209-03
|
|
Mycobacterial PDIM/PGL: synthesis pathway and inhibition
|
QUADRI, LUIS
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$313,427
|
Tuberculosis
|
FIC
|
2K01TW006083-05A1
|
|
Genomic and immunological comparisons of M africanum and M tuberculosis
|
DE JONG, BOUKE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$119,843
|
Tuberculosis
|
FIC
|
1K01TW008005-01
|
|
The Role of Immune Reconstitution Inflammatory Syndrome (IRIS) in Pulmonary Tuber
|
MURDOCH, DAVID
|
DUKE UNIVERSITY
|
NC
|
$112,137
|
Tuberculosis
|
NIAID
|
5R01AI064798-04
|
|
Biogenesis of lipoarabinomannan in mycobacteria
|
JACKSON, MARY
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$326,298
|
Tuberculosis
|
NIAID
|
5R01AI015495-26
|
|
Dietary Deficiencies and Tuberculosis Vaccine Efficacy
|
MCMURRAY, DAVID
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
TX
|
$270,678
|
Tuberculosis
|
NIAID
|
5R01AI059114-05
|
|
Integration and excision by serine-integrases
|
HATFULL, GRAHAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$335,406
|
Tuberculosis
|
NHLBI
|
5K24HL004074-09
|
|
Mentoring in Tuberculosis Patient-Oriented Research
|
SCHLUGER, NEIL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$152,290
|
Tuberculosis
|
NIAID
|
5R01AI044063-09
|
|
Mode of Action of Pyrazinamide in Tubercle Bacillus
|
ZHANG, YING
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$305,094
|
Tuberculosis
|
NIAID
|
5R01AI063446-03
|
|
Conditional Expression of Mycobacterial Genes
|
EHRT, SABINE
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$400,072
|
Tuberculosis
|
NIAID
|
5R01AI063432-04
|
|
Porins of Mycobacterium tuberculosis
|
NIEDERWEIS, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$338,347
|
Tuberculosis
|
NIAID
|
5R01AI059667-05
|
|
Type I Interferons in Immunity to Tuberculosis
|
ERNST, JOEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$392,994
|
Tuberculosis
|
NIAID
|
1R01AI073891-01A1
|
|
Four Mtb Membrane Proteins: Structure and Function
|
CROSS, TIMOTHY
|
FLORIDA STATE UNIVERSITY
|
FL
|
$413,511
|
Tuberculosis
|
NLM
|
1R01LM009731-01
|
|
Discovering hidden groups across tuberculosis patient and pathogen genotype data
|
BENNETT, KRISTIN
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$342,967
|
Tuberculosis
|
NIAID
|
5R01AI044373-09
|
|
Human T Cell Antigens of Mycobacterium tuberculosis
|
REED, STEVEN
|
INFECTIOUS DISEASE RESEARCH INSTITUTE
|
WA
|
$470,628
|
Tuberculosis
|
NIAID
|
5R01AI036396-15
|
|
Genetic Basis of Mycobacterial Invasion
|
RAMAKRISHNAN, LALITA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$348,861
|
Tuberculosis
|
NIAID
|
1K08AI076351-01
|
|
Characterization of the phagosome during Mycobacterium tuberculosis infection
|
NOLT, DAWN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$130,275
|
Tuberculosis
|
NIAID
|
5R01AI065850-03
|
|
Discovering New Anti-Tuberculosis Drugs
|
THOMAS, MICHAEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$302,740
|
Tuberculosis
|
NIAID
|
1R21AI076685-01
|
|
A Reporter Transposon for Studying Exported Proteins of M. tuberculosis
|
BRAUNSTEIN, MIRIAM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$181,495
|
Tuberculosis
|
NIAID
|
5R37AI026170-20
|
|
Molecular Genetic Analysis of Mycobacterium tuberculosis
|
JACOBS, WILLIAM
|
YESHIVA UNIVERSITY
|
NY
|
$419,399
|
Tuberculosis
|
NIAID
|
5R01AI064693-04
|
|
DNA Ligases in Mycobacterial DNA repair & Pathogenesis
|
GLICKMAN, MICHAEL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$424,620
|
Tuberculosis
|
NIAID
|
1K08AI076620-01
|
|
Biofilm formation in mycobacterial persistence and drug tolerance in vivo
|
CONNOLLY, LYNN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$132,911
|
Tuberculosis
|
NIAID
|
5K08AI055985-06
|
|
Molecular approaches for understanding TB dynamics
|
COHEN, THEODORE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$128,520
|
Tuberculosis
|
NIAID
|
5R01AI061505-04
|
|
The Mycobacterium Tuberculosis Dormancy Program
|
VOSKUIL, MARTIN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$345,713
|
Tuberculosis
|
NHLBI
|
5R01HL081149-03
|
|
Impact of Diabetes and Hyperlipidemia on Host Defense
|
KORNFELD, HARDY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$394,469
|
Tuberculosis
|
NIAID
|
5R01AI063200-03
|
|
Fluoroquinolone Resistance in M. Tuberculosis
|
STERLING, TIMOTHY
|
VANDERBILT UNIVERSITY
|
TN
|
$365,542
|
Tuberculosis
|
NIAID
|
5K08AI064229-04
|
|
Modeling latent TB Infection
|
KARAKOUSIS, PETROS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$139,320
|
Tuberculosis
|
NIAID
|
1R21AI076941-01
|
|
Effects of carbon dioxide on M. tuberculosis growth and gene expression
|
MCDONOUGH, KATHLEEN
|
WADSWORTH CENTER
|
NY
|
$219,544
|
Tuberculosis
|
NIAID
|
5R01AI060014-04
|
|
Catalysis of isoniazid action by M tuberculosis KatG
|
MAGLIOZZO, RICHARD
|
BROOKLYN COLLEGE
|
NY
|
$320,211
|
Tuberculosis
|
NIAID
|
5R01AI063514-04
|
|
Regulation of IFN-gamma production in human tuberculosis
|
BARNES, PETER
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$255,795
|
Tuberculosis
|
NIAID
|
2R01AI052291-04A2
|
|
Mechanisms of Macrolide Resistance in Mycobacteria
|
NASH, KEVIN
|
CHILDREN'S HOSPITAL LOS ANGELES
|
CA
|
$275,625
|
Tuberculosis
|
NIAID
|
5R01AI064522-02
|
|
Immune correlates of reactivation tuberculosis
|
TURNER, JOANNE
|
OHIO STATE UNIVERSITY
|
OH
|
$367,875
|
Tuberculosis
|
NIAID
|
2R01AI049151-05A1
|
|
Menaquinone biosynthesis:a drug target in Gram-positive bacteria
|
CRICK, DEAN
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$348,500
|
Tuberculosis
|
NIAID
|
5R01AI037139-11
|
|
Structure of LAM in Relation to Biology and Biosynthesis
|
CHATTERJEE, DELPHI
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$236,030
|
Tuberculosis
|
NIAID
|
5R01AI069161-03
|
|
Anti-tuberculosis vaccination: The role of macrophages
|
NORTH, ROBERT
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$375,067
|
Tuberculosis
|
NIGMS
|
1R01GM079618-01A1
|
|
Principles of Protein Mimicry of DNA
|
BRENOWITZ, MICHAEL
|
YESHIVA UNIVERSITY
|
NY
|
$340,300
|
Tuberculosis
|
NIAID
|
5R01AI063499-04
|
|
cAMP signaling in Mycobacterium tuberculosis
|
MCDONOUGH, KATHLEEN
|
WADSWORTH CENTER
|
NY
|
$277,569
|
Tuberculosis
|
NIAID
|
5K23AI068458-03
|
|
The Efficacy and Impact of Routine HIV and TB Testing in Durban, South Africa
|
BASSETT, INGRID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$133,920
|
Tuberculosis
|
NHLBI
|
5R01HL083839-03
|
|
Investigation of the role of bacteria in the sarcoidosis trimolecular complex
|
DRAKE, WONDER
|
VANDERBILT UNIVERSITY
|
TN
|
$373,077
|
Tuberculosis
|
NIGMS
|
5R01GM054226-11
|
|
Control of DNA Topology
|
TSE-DINH, YUK-CHING
|
NEW YORK MEDICAL COLLEGE
|
NY
|
$292,878
|
Tuberculosis
|
NIAID
|
2R01AI033696-16A1
|
|
Mechanism Based Inhibition of M Tuberculosis Enzymes
|
BLANCHARD, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$651,113
|
Tuberculosis
|
NIAID
|
5R37AI014107-33
|
|
Control of Bacterial Toxins by Viruses and Plasmids
|
HOLMES, RANDALL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$463,104
|
Tuberculosis
|
NIAID
|
5R01AI064768-04
|
|
Targets in Mycobacterium Tuberculosis: Stress Resistance & Repair
|
NATHAN, CARL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$861,514
|
Tuberculosis
|
NIAID
|
5R01AI048417-07
|
|
Mycobacterium tuberculosis cell division and proliferation
|
RAJAGOPALAN, MALINI
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$337,219
|
Tuberculosis
|
NHLBI
|
5R01HL072817-05
|
|
Effectiveness of the TB Contact Priority Model
|
GERALD, LYNN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$563,493
|
Tuberculosis
|
NIAID
|
5R01AI044072-10
|
|
Chronic Tuberculosis: Latent or Dynamic
|
ORME, IAN
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$302,187
|
Tuberculosis
|
FIC
|
5U2RTW006896-05
|
|
Haiti AIDS Research Training: Models to Implementation
|
PAPE, JEAN
|
GHESKIO CENTER
|
HAITI
|
$275,794
|
Tuberculosis
|
NIMH
|
5U2RTW006896-05
|
|
Haiti AIDS Research Training: Models to Implementation
|
PAPE, JEAN
|
GHESKIO CENTER
|
HAITI
|
$100,000
|
Tuberculosis
|
FIC
|
5U2RTW006900-05
|
|
Uganda HIV/TB COHRE Training Program
|
WHALEN, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$20,246
|
Tuberculosis
|
NINDS
|
5U2RTW006900-05
|
|
Uganda HIV/TB COHRE Training Program
|
WHALEN, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$120,000
|
Tuberculosis
|
NIAID
|
5K24AI001637-09
|
|
Clinical Research in Tuberculosis
|
CHAISSON, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$155,375
|
Tuberculosis
|
NCRR
|
1S10RR024661-01
|
|
400 MHz NMR Spectrometer
|
JOHNSON, RODNEY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$345,500
|
Tuberculosis
|
NIAID
|
5R01AI063031-04
|
|
M Tuberculosis and Host-Defense Mechanisms
|
TING, JENNY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$338,074
|
Tuberculosis
|
NIAID
|
5R01AI058810-05
|
|
Vaccination strategies against pulmonary tuberculosis
|
RAMSAY, ALISTAIR
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$198,126
|
Tuberculosis
|
NIAID
|
5R01AI049313-08
|
|
T-Cell response to CD1-restricted lipids in Tuberculosis
|
MOODY, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$416,742
|
Tuberculosis
|
NIAID
|
5R01AI042801-08
|
|
Epidemiology of Helicobacter Pylori Transmission
|
PARSONNET, JULIE
|
STANFORD UNIVERSITY
|
CA
|
$681,962
|
Tuberculosis
|
NIAID
|
1R21AI073612-01A1
|
|
The role of regulatory T cells in M. tuberculosis infection
|
VANKAYALAPATI, RAMAKRISHNA
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$196,875
|
Tuberculosis
|
NIGMS
|
2R01GM049975-14
|
|
Glycopeptides and Other Non-Natural Variants: Probes of Carbohydrate Function
|
KIESSLING, LAURA
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$341,699
|
Tuberculosis
|
NCRR
|
1S10RR024653-01
|
|
Circular Dichroism Spectrometer
|
ROUSSEAU, DENIS
|
YESHIVA UNIVERSITY
|
NY
|
$150,187
|
Tuberculosis
|
NHLBI
|
5K01HL076632-06
|
|
Mechanisms of cell growth arrest in latent tuberculosis.
|
FONTAN, PATRICIA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$136,710
|
Tuberculosis
|
NIAID
|
5R01AI065744-03
|
|
Role of mycobacteria in sarcoidosis immunopathogenesis
|
DRAKE, WONDER
|
VANDERBILT UNIVERSITY
|
TN
|
$364,456
|
Tuberculosis
|
NCRR
|
1S10RR024681-01
|
|
400 MHz NMR Spectrometer for CSU Chemistry Facility
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$250,773
|
Tuberculosis
|
NIAID
|
5K24AI001833-05
|
|
TB Clinical Research: Training the Next Generation
|
HAMILTON, CAROL
|
DUKE UNIVERSITY
|
NC
|
$101,331
|
Tuberculosis
|
NIAID
|
1R43AI077025-01
|
|
Simple and Rapid On-site molecular detection of Mycobacterium tuberculosis
|
MONTAGNA, RICHARD
|
INNOVATIVE BIOTECHNOLOGIES INTERNATIONAL
|
NY
|
$99,975
|
Tuberculosis
|
NIAID
|
5F31AI061836-04
|
|
Expression of MTB and Host Genes in Early Tuberculosis
|
ESTRELLA, JAYMIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$30,522
|
Tuberculosis
|
NIAID
|
5R01AI072133-02
|
|
Whole cell and essential enzyme screening assays for mycothiol biosynthesis
|
FAHEY, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$265,238
|
Tuberculosis
|
NIAID
|
5R01AI064282-02
|
|
Mce transport systems of Mycobacterium tuberculosis
|
SASSETTI, CHRISTOPHER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$355,919
|
Tuberculosis
|
NHLBI
|
5R01HL071241-07
|
|
Cell Migration in Tuberculosis Infection
|
CHAN, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$387,256
|
Tuberculosis
|
NIAID
|
5R01AI070285-02
|
|
Structural studies of the M. tuberculosis proteasome and proteasomal ATPase
|
LI, HUILIN
|
BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB
|
NY
|
$364,986
|
Tuberculosis
|
FIC
|
5D43TW007124-05
|
|
Emory-Georgia TB Research Training Program
|
BLUMBERG, HENRY
|
EMORY UNIVERSITY
|
GA
|
$111,625
|
Tuberculosis
|
NIAID
|
5R01AI042308-10
|
|
Conjugation and recombination in mycobacteria
|
DERBYSHIRE, KEITH
|
WADSWORTH CENTER
|
NY
|
$318,292
|
Tuberculosis
|
FIC
|
5U2RTW006901-05
|
|
HAITI AIDS RESEARCH TRAINING: MODELS TO IMPLEMENTATION
|
JOHNSON, WARREN
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$16,116
|
Tuberculosis
|
NINDS
|
5U2RTW006901-05
|
|
HAITI AIDS RESEARCH TRAINING: MODELS TO IMPLEMENTATION
|
JOHNSON, WARREN
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$150,000
|
Tuberculosis
|
NIGMS
|
5R01GM070962-04
|
|
Functions and mechanisms of M. tuberculosis S/T kinases
|
ALBER, THOMAS
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$246,249
|
Tuberculosis
|
NIAID
|
5R01AI065697-04
|
|
TB Vaccine Development in Nonhuman Primate Model
|
VANDEBERG, JOHN
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$790,437
|
Tuberculosis
|
NIAID
|
5U01AI058257-05
|
|
Haitian Program for Research and Training in HIV/AIDS
|
PAPE, JEAN
|
GHESKIO CENTER
|
HAITI
|
$500,636
|
Tuberculosis
|
FIC
|
5U2RTW006879-05
|
|
UGANDA HIV/TB COHRE TRAiNING PROGRAM
|
MUGYENYI, PETER
|
JOINT CLINICAL RESEARCH CENTER
|
UGANDA
|
$405,311
|
Tuberculosis
|
NIAID
|
5R01AI065285-04
|
|
HIV-1 regulation by MTb: pathogen and host factor
|
GOLDFELD, ANNE
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$440,433
|
Tuberculosis
|
NIAID
|
1R43AI077137-01
|
|
Rapid and Enclosed System for the Identification of Multi-Drug Resistant TB
|
WONG, SEASON
|
LYNNTECH, INC.
|
TX
|
$145,242
|
Tuberculosis
|
NIAID
|
5R01AI051669-07
|
|
M. tuberculosis Genes Regulating Persistent Infection
|
ZAHRT, THOMAS
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$334,398
|
Tuberculosis
|
NIAID
|
1R43AI077163-01
|
|
Multiplex Microarray for Tuberculosis
|
AWDEH, ZUHEIR
|
PULSAR CLINICAL TECHNOLOGIES, INC.
|
MA
|
$120,209
|
Tuberculosis
|
NIAID
|
5U01AI069521-02
|
|
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
|
COTTON, MARK
|
STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS
|
SO AFR
|
$1,471,428
|
Tuberculosis
|
NIAID
|
1R43AI077167-01
|
|
Development of a phage-based nucleic acid amplification diagnostic for the rapid
|
MULVEY, MATTHEW
|
SEQUELLA, INC.
|
MD
|
$244,346
|
Tuberculosis
|
NIAID
|
5R21AI073509-02
|
|
Targets for short-course TB therapy
|
SASSETTI, CHRISTOPHER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$239,119
|
Tuberculosis
|
FIC
|
1R13NS061368-01
|
|
Infectious Diseases of the Nervous System: Pathogenesis and Worldwide Impact
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$5,000
|
Tuberculosis
|
NIAID
|
1R13NS061368-01
|
|
Infectious Diseases of the Nervous System: Pathogenesis and Worldwide Impact
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$10,000
|
Tuberculosis
|
NIMH
|
1R13NS061368-01
|
|
Infectious Diseases of the Nervous System: Pathogenesis and Worldwide Impact
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$2,000
|
Tuberculosis
|
NINDS
|
1R13NS061368-01
|
|
Infectious Diseases of the Nervous System: Pathogenesis and Worldwide Impact
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$5,000
|
Tuberculosis
|
OD
|
1R13NS061368-01
|
|
Infectious Diseases of the Nervous System: Pathogenesis and Worldwide Impact
|
GRIFFIN, DIANE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$25,000
|
Tuberculosis
|
NIAID
|
5K23AI054443-05
|
|
Immunoepidemiology of Concomittant Infection
|
PERRY, SHARON
|
STANFORD UNIVERSITY
|
CA
|
$131,490
|
Tuberculosis
|
NIAID
|
5R01AI043268-10
|
|
INH-induced lysis of the HIV opportunistic infection, M. tuberculosis
|
JACOBS, WILLIAM
|
YESHIVA UNIVERSITY
|
NY
|
$627,577
|
Tuberculosis
|
NIAID
|
5R01AI020958-24
|
|
Galectins and Innate Immunity
|
LIU, FU-TONG
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$276,259
|
Tuberculosis
|
NIGMS
|
5R01GM076685-03
|
|
Checkpoints of TNF Gene Regulation
|
GOLDFELD, ANNE
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$340,229
|
Tuberculosis
|
NIAID
|
1F31AI075897-01A1
|
|
Evaluation of laboratory information systems in resource-poor settings
|
BLAYA, JOAQUIN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$29,772
|
Tuberculosis
|
NIAID
|
5R01AI043241-07
|
|
Purine Analog Anti-Mycobacterial Drug Development
|
PARKER, WILLIAM
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$453,972
|
Tuberculosis
|
NIAID
|
5K24AI065298-04
|
|
Mentoring in HIV and Tuberculosis Research
|
STERLING, TIMOTHY
|
VANDERBILT UNIVERSITY
|
TN
|
$167,664
|
Tuberculosis
|
NIAID
|
5R01AI054503-06
|
|
Host Responses to Mycobacterium Infection in Zebrafish
|
RAMAKRISHNAN, LALITA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$377,780
|
Tuberculosis
|
NIAID
|
5R01AI060899-05
|
|
Bacterial N-Acetyltransferases: Resistance to Regulation
|
BLANCHARD, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$449,911
|
Tuberculosis
|
NIAID
|
5R01AI069395-02
|
|
Heminth Modulation of Mtb
|
SALGAME, PADMINI
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$529,987
|
Tuberculosis
|
NIAID
|
5R01AI068517-02
|
|
Structure of M. tuberculosis Adenosine Kinase and Design of Antimicrobial Nucle
|
LI, RONGBAO
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$345,536
|
Tuberculosis
|
NIAID
|
5R01AI063596-04
|
|
The Chemistry and Biology of Galactofuranose Residues
|
KIESSLING, LAURA
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$299,427
|
Tuberculosis
|
NIAID
|
5R01AI073491-02
|
|
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis
|
DRLICA, KARL
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$696,668
|
Tuberculosis
|
NHLBI
|
5R01HL055967-13
|
|
M. tuberculosis Infection in the Lung
|
BOOM, W
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$479,432
|
Tuberculosis
|
NIAID
|
1R43AI074476-01A1
|
|
Diagnosis of Extra-Pulmonary Tuberculosis in HIV Patients
|
RIEDER, RONALD
|
BIOSENSE TECHNOLOGIES, INC.
|
MA
|
$100,000
|
Tuberculosis
|
NIAID
|
5K08AI064014-04
|
|
Lung macrophage innate receptor response to MTb in HIV
|
PATEL, NAIMISH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$123,579
|
Tuberculosis
|
NIAID
|
5R01AI031338-16
|
|
Development and Testing of New Tuberculosis Vaccines
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$690,878
|
Tuberculosis
|
NIAID
|
5K08AI053542-05
|
|
Macrophage defense againt M. tuberculosis
|
WANG, JENNIFER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$123,903
|
Tuberculosis
|
NIMH
|
1R34MH082662-01
|
|
ASHA HIV Health Promotion Intervention in India
|
NYAMATHI, ADELINE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$227,163
|
Tuberculosis
|
NIAID
|
5K08AI063303-04
|
|
Role of Lrp-like proteins in MTB Pathogenesis
|
HASSANI, MORAD
|
YESHIVA UNIVERSITY
|
NY
|
$127,710
|
Tuberculosis
|
NIAID
|
5R01AI064494-03
|
|
Phage mimicry of mycobacterial signaling
|
HATFULL, GRAHAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$516,690
|
Tuberculosis
|
NIAID
|
5R01AI058131-05
|
|
Role of WhiB3 in M. tuberculosis virulence
|
STEYN, ANDRIES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$337,184
|
Tuberculosis
|
NHLBI
|
5R01HL084347-03
|
|
MCP-1 and MMP-1 contributions in susceptibility to developing active tuberculosis
|
FLORES-VILLANUEVA, PEDRO
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
TX
|
$345,747
|
Tuberculosis
|
NIMH
|
5R01MH075637-03
|
|
Family-Based HIV VCT in Patients at Risk for TB
|
CHARLEBOIS, EDWIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$448,531
|
Tuberculosis
|
FIC
|
5D43TW001403-08
|
|
International Training in AIDS/TB Prevention Research
|
PRASAD, VINAYAKA
|
YESHIVA UNIVERSITY
|
NY
|
$186,347
|
Tuberculosis
|
NHLBI
|
5D43TW001403-08
|
|
International Training in AIDS/TB Prevention Research
|
PRASAD, VINAYAKA
|
YESHIVA UNIVERSITY
|
NY
|
$211,819
|
Tuberculosis
|
NIAID
|
5K08AI058993-05
|
|
Defining Moxifloxacin as a First-line TB Drug
|
NUERMBERGER, ERIC
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$129,330
|
Tuberculosis
|
NIAID
|
5R01AI067723-03
|
|
The role of IL-12p40 in the response of pulmonary dendritic cells to tuberculosis
|
COOPER, ANDREA
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$416,742
|
Tuberculosis
|
NIGMS
|
5R01GM061028-08
|
|
Molecular Mechanisms of Mechanosensitive Channel Gating
|
BLOUNT, PAUL
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$307,788
|
Tuberculosis
|
NIAID
|
5R01AI027243-20
|
|
Heterogeneity of T-cells in M. tuberculosis Infection
|
BOOM, W
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$341,020
|
Tuberculosis
|
NIGMS
|
1R01GM083953-01
|
|
Structure and Mechanism of SAM-responsive Riboswitches
|
BATEY, ROBERT
|
UNIVERSITY OF COLORADO AT BOULDER
|
CO
|
$293,616
|
Tuberculosis
|
NIAID
|
5R01AI059702-05
|
|
Characterization of M. tuberculosis kinases PknA & PknB
|
HUSSON, ROBERT
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$353,697
|
Tuberculosis
|
NIAID
|
5K01AI066994-04
|
|
Epidemiologic Strategies for Tuberculosis Control
|
GOLUB, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$115,289
|
Tuberculosis
|
NIAID
|
5R01AI068942-02
|
|
Characterization of NADH Type II oxidoreductase from mycobacterium tuberculosis
|
RUBIN, HARVEY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$368,894
|
Tuberculosis
|
NIAID
|
5R01AI046097-10
|
|
M. tuberculosis evasion of immune effector mechanisms
|
ERNST, JOEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$501,088
|
Tuberculosis
|
NHLBI
|
5R01HL088906-04
|
|
Mycobacterium tuberculosis carbon metabolism in vivo
|
MCKINNEY, JOHN
|
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
|
SWITZE
|
$270,000
|
Tuberculosis
|
NIAID
|
5R01AI072143-02
|
|
Role of lipid mediators in host resistance to Mycobacterium tuberculosis
|
REMOLD, HEINZ
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$417,547
|
Tuberculosis
|
NIAID
|
5R01AI015066-30
|
|
Cell Surface Receptors on T cells and Macrophages
|
TERHORST, CORNELIS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$416,925
|
Tuberculosis
|
NHLBI
|
5R01HL055936-13
|
|
The Role of The Granuloma in M. Tuberculosis Infections
|
RUSSELL, DAVID
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$386,333
|
Tuberculosis
|
NIGMS
|
5R01GM056676-11
|
|
Tethered Domains As Regulatory Elements
|
GRANT, GREGORY
|
WASHINGTON UNIVERSITY
|
MO
|
$342,850
|
Tuberculosis
|
FIC
|
5U2RTW007367-04
|
|
African Programe for Training in HIV/TB Research
|
MASON, PETER
|
BIOMEDICAL RESEARCH & TRAINING INSTITUTE
|
ZMBBWE
|
$427,803
|
Tuberculosis
|
FIC
|
5U2RTW006883-04
|
|
Innovative approaches for tuberculosis control in Brazil
|
LAPA E SILVA, JOSE
|
FEDERAL UNIVERSITY OF RIO DE JANEIRO
|
BRAZIL
|
$349,075
|
Tuberculosis
|
NHLBI
|
5R01HL064884-08
|
|
Antimycobacterial Mechanisms of Apoptosis in the Lung
|
KORNFELD, HARDY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$394,469
|
Tuberculosis
|
NIAID
|
5R37AI052731-08
|
|
Innate NKT Cells in HIV Infection
|
NIXON, DOUGLAS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$290,916
|
Tuberculosis
|
NHLBI
|
5R01HL057879-10
|
|
HIV/TB Interaction in the Lung
|
WEIDEN, MICHAEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$482,892
|
Tuberculosis
|
NIAID
|
5R21AI073182-02
|
|
BCG as an HIV vaccine vector
|
WILLIAMSON, ANNA-LISE
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$150,386
|
Tuberculosis
|
NIAID
|
5R01AI065987-05
|
|
Fatty Acid Metabolism's Role in Mycobacterium tuberculosis virulence
|
SMITH, ISSAR
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$362,764
|
Tuberculosis
|
NIAID
|
5R01AI071155-03
|
|
Remodeling of the M. tuberculosis cell wall during infection
|
MOODY, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$416,742
|
Tuberculosis
|
NIAID
|
1U01AI078054-01
|
|
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
|
COLER, RHEA
|
INFECTIOUS DISEASE RESEARCH INSTITUTE
|
WA
|
$979,306
|
Tuberculosis
|
NIAID
|
5R01AI051667-08
|
|
Secretion of Virulence Factors by Mycobacterium tuberculosis
|
COX, JEFFERY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$460,114
|
Tuberculosis
|
FIC
|
5U2RTW006878-04
|
|
African Programe for Training in HIV/TB Research
|
KATZENSTEIN, DAVID
|
STANFORD UNIVERSITY
|
CA
|
$22,197
|
Tuberculosis
|
NINDS
|
5U2RTW006878-04
|
|
African Programe for Training in HIV/TB Research
|
KATZENSTEIN, DAVID
|
STANFORD UNIVERSITY
|
CA
|
$100,000
|
Tuberculosis
|
NIAID
|
5R03AI072065-02
|
|
Function of SecA2 in Mycobacterium tuberculosis protein export
|
TESCHKE, CAROLYN
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$74,556
|
Tuberculosis
|
NIGMS
|
5R01GM066014-07
|
|
Structure and Assembly Dynamics of FtsZ
|
ERICKSON, HAROLD
|
DUKE UNIVERSITY
|
NC
|
$433,013
|
Tuberculosis
|
FIC
|
5U2RTW006877-05
|
|
TB-AIDS Clinical Training and Research Unit, Russia
|
KOZLOV, ANDREI
|
BIOMEDICAL CENTER
|
RUSS
|
$63,000
|
Tuberculosis
|
NIDA
|
5U2RTW006877-05
|
|
TB-AIDS Clinical Training and Research Unit, Russia
|
KOZLOV, ANDREI
|
BIOMEDICAL CENTER
|
RUSS
|
$49,000
|
Tuberculosis
|
FIC
|
5U2RTW006893-05
|
|
TB-AIDS Clinical Training and Research Unit, Russia
|
HEIMER, ROBERT
|
YALE UNIVERSITY
|
CT
|
$166,320
|
Tuberculosis
|
NHLBI
|
5R01HL080312-05
|
|
Treatment of tuberculosis with immunomodulators
|
BEHAR, SAMUEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$370,635
|
Tuberculosis
|
NIAID
|
1R21AI078509-01
|
|
Acquired susceptibility to pulmonary TB
|
KORNFELD, HARDY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$204,375
|
Tuberculosis
|
NIAID
|
5R44AI069574-03
|
|
Rapid, easy nucleic acid-based detection of pulmonary tuberculosis
|
KOSHINSKY, HEATHER
|
INVESTIGEN, INC.
|
CA
|
$130,141
|
Tuberculosis
|
NIAID
|
5R21AI064018-02
|
|
Post Translation Regulation in Mycobacteria
|
BERMUDEZ, LUIZ
|
OREGON STATE UNIVERSITY
|
OR
|
$179,278
|
Tuberculosis
|
NIAID
|
5K23AI067665-02
|
|
Immunodiagnostic Tests for the Rapid Diagnosis of Tb
|
ACHKAR, JACQUELINE
|
YESHIVA UNIVERSITY
|
NY
|
$133,110
|
Tuberculosis
|
NIGMS
|
5R01GM081706-02
|
|
Characterization of the Suf Fe-S Cluster Biosynthesis Pathway Under Stress
|
OUTTEN, FRANKLIN
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$217,589
|
Tuberculosis
|
FIC
|
5U2RTW007370-02
|
|
South Africa Tuberculosis AIDS Training (SATBAT)
|
MARTINSON, NEIL
|
WITS HEALTH CONSORTIUM (PTY), LTD
|
SO AFR
|
$291,501
|
Tuberculosis
|
FIC
|
5U2RTW007373-02
|
|
South Africa Tuberculosis/AIDS Training
|
VAN DER HORST, CHARLES
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$270,542
|
Tuberculosis
|
NIAID
|
1R01AI072584-01A2
|
|
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
|
BRIKEN, VOLKER
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$143,751
|
Tuberculosis
|
NIAID
|
5R01AI065653-04
|
|
Protective immunity induced by newborn BCG vaccination
|
HANEKOM, WILLEM
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$501,445
|
Tuberculosis
|
NHLBI
|
5R01HL051636-15
|
|
Impact of Tuberculosis on HIV Disease
|
TOOSSI, ZAHRA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$344,085
|
Tuberculosis
|
NIGMS
|
2R01GM054469-18
|
|
Sulfate Adenylation-Biochemistry & Enzymology
|
LEYH, THOMAS
|
YESHIVA UNIVERSITY
|
NY
|
$431,989
|
Tuberculosis
|
NIAID
|
5R21AI071844-02
|
|
TLR2 Regulation of Host Immune Response in TB
|
SALGAME, PADMINI
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$191,295
|
Tuberculosis
|
NIAID
|
5R01AI069996-03
|
|
TB-related Immune Reconstitution Syndrome in HIV-1 Infected South Africans
|
AZZONI, LIVIO
|
WISTAR INSTITUTE
|
PA
|
$315,073
|
Tuberculosis
|
FIC
|
5U2RTW006885-04
|
|
Innovative Approaches for Tuberculosis Control in Brazil
|
CHAISSON, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$200,925
|
Tuberculosis
|
NIAID
|
5R01AI076199-02
|
|
The Utility of Interferon-Gamma Release Assays in TB-HIV co-infected Children
|
MANDALAKAS, ANNA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$544,343
|
Tuberculosis
|
NIAID
|
5R01AI075603-02
|
|
Diagnostic yield of induced sputum for rapid diagnosis of pulmonary tuberculosis
|
HATHERILL, MARK
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$79,461
|
Tuberculosis
|
FIC
|
5U01AI061736-05
|
|
A Cambodian Clinical Research Network for HIV & TB
|
THIM, SOK
|
CAMBODIAN HEALTH COMMITTEE
|
CAMBDA
|
$50,000
|
Tuberculosis
|
NIAID
|
5U01AI061736-05
|
|
A Cambodian Clinical Research Network for HIV & TB
|
THIM, SOK
|
CAMBODIAN HEALTH COMMITTEE
|
CAMBDA
|
$497,195
|
Tuberculosis
|
NIAID
|
5R03AI060856-02
|
|
Tuberculosis Diagnostics: Towards More Precise Testing in Children
|
BELLANTI, JOSEPH
|
GEORGETOWN UNIVERSITY
|
DC
|
$76,126
|
Tuberculosis
|
NIAID
|
5R01AI068041-03
|
|
Immune control of tuberculosis by IFN-gamma-inducible LRG-47
|
MACMICKING, JOHN
|
YALE UNIVERSITY
|
CT
|
$315,294
|
Tuberculosis
|
NIAID
|
5K08AI071111-02
|
|
Chemokines and their receptors in the pathogenesis of tuberculosis
|
BEAMER, GILLIAN
|
OHIO STATE UNIVERSITY
|
OH
|
$124,356
|
Tuberculosis
|
NIAID
|
1R03AI073469-01A1
|
|
Intracellular mycobacterial proteome
|
LI, QINGBO
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$78,500
|
Tuberculosis
|
NIAID
|
1R21AI072638-01A2
|
|
Traffic from chronic mycobacterium induced granulomas
|
SANDOR, MATYAS
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$181,745
|
Tuberculosis
|
NIAID
|
1R01AI069121-01A2
|
|
T cell memory to TB in the lung
|
COOPER, ANDREA
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$445,000
|
Tuberculosis
|
NIAID
|
2R01AI045658-06A2
|
|
Gene expression in M. tuberculosis
|
MCDONOUGH, KATHLEEN
|
WADSWORTH CENTER
|
NY
|
$373,462
|
Tuberculosis
|
NIGMS
|
5R01GM079185-02
|
|
Structural and functional studies of a PhoP-PhoR two-component system
|
WANG, SHUISHU
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$20,837
|
Tuberculosis
|
NIAID
|
1R01AI075038-01A2
|
|
Control of Immune responses by lipoxins during tuberculosis
|
ALIBERTI, JULIO
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$300,000
|
Tuberculosis
|
NIAID
|
1R21AI070789-01A2
|
|
Virulence factors of clinical MTB strains with enhanced growth in macrophages
|
EISENACH, KATHLEEN
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$181,148
|
Tuberculosis
|
NIAID
|
5R01AI054338-08
|
|
Host-Pathogen Determinants of M.tb Latency
|
KAPLAN, GILLA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$556,195
|
Tuberculosis
|
NCRR
|
5R24RR022907-03
|
|
Novel Immunoassays for Mycobacteria Detection in Non-human Primates
|
LUCIW, PAUL
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$597,851
|
Tuberculosis
|
NIA
|
5R01AG021097-05
|
|
CD8 T Cells and Immunity to Tuberculosis in Old Mice
|
TURNER, JOANNE
|
OHIO STATE UNIVERSITY
|
OH
|
$302,880
|
Tuberculosis
|
FIC
|
5U2RTW007374-02
|
|
Peru ICOHRTA Network for AIDS/TB Research Training
|
HOLMES, KING
|
UNIVERSITY OF WASHINGTON
|
WA
|
$109,793
|
Tuberculosis
|
NINDS
|
5U2RTW007374-02
|
|
Peru ICOHRTA Network for AIDS/TB Research Training
|
HOLMES, KING
|
UNIVERSITY OF WASHINGTON
|
WA
|
$80,000
|
Tuberculosis
|
NIAID
|
5R01AI066046-04
|
|
Host-Pathogen Interactions and M.tb Drug Resistance
|
KAPLAN, GILLA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$323,659
|
Tuberculosis
|
NIAID
|
5R21AI072136-02
|
|
Thioesterase Inhibitors of Mycolic Acid Biosynthesis as Antitubercular Agents
|
ALDRICH, COURTNEY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$219,989
|
Tuberculosis
|
NIAID
|
5R01AI070219-03
|
|
Design of antituberculosis agents that target siderophore biosynthesis
|
ALDRICH, COURTNEY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$284,812
|
Tuberculosis
|
NIAID
|
5K08AI067458-03
|
|
Population Genetics of M. Tuberculosis During Disease Epidemics
|
PEPPERELL, CAITLIN
|
STANFORD UNIVERSITY
|
CA
|
$116,505
|
Tuberculosis
|
NIAID
|
5R01AI074824-02
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis
|
ORTIZ DE MONTELLANO, PAUL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$401,130
|
Tuberculosis
|
NCRR
|
5R01RR013601-10
|
|
Role of CD8 T cells in immunity to tuberculosis
|
CHEN, ZHENG
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$642,746
|
Tuberculosis
|
NHLBI
|
5K25HL075105-04
|
|
Analyzing the Genetic Basis of Mtb Latency/Reactivation
|
MAY, ELEBEOBA
|
SANDIA CORP-SANDIA NATIONAL LABORATORIES
|
NM
|
$153,601
|
Tuberculosis
|
NIDA
|
5R21DA023543-02
|
|
Opiate Modulates Lymphocyte Trafficking into the CNS in TB Meningitis
|
MOLITOR, THOMAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$146,510
|
Tuberculosis
|
FIC
|
5U2RTW007368-02
|
|
Peru ICOHRTA Network for AIDS/TB Research Training
|
GOTUZZO, EDUARDO
|
UNIVERSIDAD PERUANA CAYETANO HEREDIA
|
PERU
|
$368,347
|
Tuberculosis
|
NIAID
|
1R13AI078600-01
|
|
Immunodiagnosis of tuberculosis: new questions, new tools
|
GENNARO, MARIA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$15,000
|
Tuberculosis
|
NIAID
|
1R43AI078605-01
|
|
RAPID AFFORDABLE TB DRUG SUSCEPTIBILITY TESTING
|
SHAPIRO, HOWARD
|
HOWARD M. SHAPIRO, MD, P.C.
|
MA
|
$299,229
|
Tuberculosis
|
NIAID
|
5F32AI063912-03
|
|
The Snm secretion system in Mycobacterium smegmatis
|
CHAMPION, PATRICIA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$52,048
|
Tuberculosis
|
NIAID
|
5R21AI068928-02
|
|
Protein-protein association in mycobacteria
|
STEYN, ADRIE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$213,368
|
Tuberculosis
|
NIAID
|
5R01AI057786-03
|
|
Epidemiology of multidrug-resistant tuberculosis in Peru
|
BECERRA, MERCEDES
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$615,660
|
Tuberculosis
|
NIAID
|
2R44AI078694-02
|
|
Rapid High-Throughput Mycobacterium Tuberculosis Genotyping
|
MASSIRE, CHRISTIAN
|
IBIS BIOSCIENCES, INC.
|
CA
|
$370,778
|
Tuberculosis
|
NIAID
|
5U01AI070456-03
|
|
Response Therapies for MDR-TB
|
ORME, IAN
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$1,131,873
|
Tuberculosis
|
NIDCR
|
1R01DE019064-01
|
|
A Novel Oral Combination Pediatric HIV and TB Vaccine
|
ABEL, KRISTINA
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$687,840
|
Tuberculosis
|
NICHD
|
5K01HD051494-04
|
|
Demographic Change and Dependent Social Structures
|
JONES, JAMES
|
STANFORD UNIVERSITY
|
CA
|
$134,407
|
Tuberculosis
|
NIAID
|
5R01AI051622-07
|
|
Mycobacterial Sulfation Pathways
|
BERTOZZI, CAROLYN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$410,946
|
Tuberculosis
|
NIAID
|
5R42AI052523-04
|
|
Sample Processing Cartridges for Rapid PCR TB Detection
|
ALLAND, DAVID
|
CEPHEID
|
CA
|
$1,160,774
|
Tuberculosis
|
NIAID
|
5R01AI045148-11
|
|
Mechanism of M. tuberculosis Phagosome Maturation Arrest
|
DERETIC, VOJO
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$390,766
|
Tuberculosis
|
FIC
|
2D43TW000018-21
|
|
AIDS International Training and Research Program
|
JOHNSON, WARREN
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$826,030
|
Tuberculosis
|
NIAID
|
5R43AI075830-02
|
|
Optimization of a Multivalent Tuberculosis Vaccine
|
DE GROOT, ANNE
|
EPIVAX, INC.
|
RI
|
$285,475
|
Tuberculosis
|
FIC
|
2D43TW006807-06
|
|
Dartmouth/Boston University AITRP
|
VON REYN, C.
|
DARTMOUTH COLLEGE
|
NH
|
$441,672
|
Tuberculosis
|
FIC
|
2D43TW000011-21
|
|
HIV/AIDS International Training Program
|
WHALEN, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$812,312
|
Tuberculosis
|
NIAID
|
5R21AI075016-02
|
|
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis
|
SMALL, PETER
|
INSTITUTE FOR SYSTEMS BIOLOGY
|
WA
|
$264,870
|
Tuberculosis
|
NIAID
|
5K01AI065836-03
|
|
Clinical Outcomes Research in MDR-TB
|
MITNICK, CAROLE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$118,040
|
Tuberculosis
|
NIAID
|
5R21AI067659-02
|
|
A smart microscope for the detection of tuberculosis in ZN-stained sputum smears
|
DOUGLAS, TANIA
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$132,435
|
Tuberculosis
|
NHLBI
|
5K24HL087713-03
|
|
Patient-Oriented Research and Mentoring in Pneumocystis
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$169,936
|
Tuberculosis
|
NIAID
|
5R01AI044856-11
|
|
Molecular Determinants of M. tuberculosis virulence
|
SMITH, ISSAR
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$488,469
|
Tuberculosis
|
NHLBI
|
5R01HL064560-11
|
|
Macaque Models of AIDS-Related Tuberculosis and T Cell
|
CHEN, ZHENG
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$797,033
|
Tuberculosis
|
FIC
|
1R01NS055628-01A2
|
|
Role of CNS Opportunistic Infections in Subsequent Development of HIV Encephaliti
|
NATH, AVINDRA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$25,000
|
Tuberculosis
|
NINDS
|
1R01NS055628-01A2
|
|
Role of CNS Opportunistic Infections in Subsequent Development of HIV Encephaliti
|
NATH, AVINDRA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$319,018
|
Tuberculosis
|
NIAID
|
5R03AI074647-02
|
|
Susceptibility of Mycobacterium tuberculosis clinical isolates to moxifloxacin
|
EL SAHLI, HANAA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$75,292
|
Tuberculosis
|
NIAID
|
5R21AI070982-02
|
|
Investigation of synergy between Rifampin and SQ109, a new anti-TB drug candidate
|
REDDY, VENKATA
|
SEQUELLA, INC.
|
MD
|
$202,331
|
Tuberculosis
|
FIC
|
5R01TW007939-02
|
|
Measuring Tobacco Mortality within the Million Death Study in India
|
JHA, PRABHAT
|
CENTRE FOR GLOBAL HEALTH RESEARCH
|
CANADA
|
$162,000
|
Tuberculosis
|
NIAID
|
5R01AI034238-15
|
|
Population Based Molecular epidemiology of Tuberculosis
|
HOPEWELL, PHILIP
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$769,038
|
Tuberculosis
|
NIAID
|
1R01AI078864-01
|
|
Immunity to and pathogeneses of M. tuberculosis and M. avium infections in mice
|
APT, ALEXANDER
|
CENTRAL INSTITUTE FOR TUBERCULOSIS
|
RUSS
|
$81,000
|
Tuberculosis
|
NIAID
|
5R03AI068044-03
|
|
Training African giant rats as a cheap diagnostic tool for early TB detection
|
WEETJENS, BART
|
APOPO VZW
|
BELGIU
|
$55,248
|
Tuberculosis
|
NIAID
|
5U01AI065663-04
|
|
US-Brazil Research Collaboration on Strain Variation in TB
|
ELLNER, JERROLD
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$482,095
|
Tuberculosis
|
NIAID
|
5R01AI075637-02
|
|
CELL TO CELL SIGNALING IN MYCOBACTERIA
|
JOLOBA, MOSES
|
MAKERERE UNIVERSITY
|
UGANDA
|
$79,461
|
Tuberculosis
|
NIAID
|
5R01AI048526-08
|
|
Novel TB Prevention Regimens for HIV-Infected Adults
|
CHAISSON, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$573,817
|
Tuberculosis
|
NIDA
|
5K08DA020398-04
|
|
Nicotine in HIV-1 and Mycobacterium tuberculosis Neuropathogenesis
|
ROCK, R
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$157,955
|
Tuberculosis
|
NIAID
|
5F32AI075805-02
|
|
Mediation of DNA Repair in Mycobacteria by CarD Proteins and ADP-RIbosylation
|
STALLINGS, CHRISTINA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$49,646
|
Tuberculosis
|
NIAID
|
5F32AI074248-02
|
|
Regulation of the CD4 T cell Response to Mycobacterium tuberculosis
|
GALLEGOS, ALENA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$49,646
|
|